Moleculin Biotech Inc (MBRX)
2.90
+0.07
(+2.47%)
USD |
NASDAQ |
Nov 22, 16:00
2.90
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Shareholders Equity (Quarterly): 7.479M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.479M |
| June 30, 2024 | 17.70M |
| March 31, 2024 | 21.59M |
| December 31, 2023 | 26.07M |
| September 30, 2023 | 35.14M |
| June 30, 2023 | 40.27M |
| March 31, 2023 | 45.68M |
| December 31, 2022 | 52.19M |
| September 30, 2022 | 58.42M |
| June 30, 2022 | 66.36M |
| March 31, 2022 | 72.66M |
| December 31, 2021 | 78.99M |
| September 30, 2021 | 81.26M |
| June 30, 2021 | 84.70M |
| March 31, 2021 | 88.52M |
| December 31, 2020 | 17.76M |
| September 30, 2020 | 14.47M |
| June 30, 2020 | 15.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.29M |
| December 31, 2019 | 15.57M |
| September 30, 2019 | 18.98M |
| June 30, 2019 | 22.09M |
| March 31, 2019 | 14.68M |
| December 31, 2018 | 14.27M |
| September 30, 2018 | 14.97M |
| June 30, 2018 | 16.75M |
| March 31, 2018 | 20.57M |
| December 31, 2017 | 17.12M |
| September 30, 2017 | 18.65M |
| June 30, 2017 | 19.27M |
| March 31, 2017 | 16.14M |
| December 31, 2016 | 14.96M |
| September 30, 2016 | 16.24M |
| June 30, 2016 | 17.23M |
| March 31, 2016 | -0.6883M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.479M
Minimum
Sep 2024
88.52M
Maximum
Mar 2021
42.79M
Average
37.70M
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies Inc | 5.903B |
| Seelos Therapeutics Inc | -28.13M |
| Cara Therapeutics Inc | 0.707M |
| Citius Pharmaceuticals Inc | 85.68M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.39M |
| Total Liabilities (Quarterly) | 15.92M |